-
2021-03-25
New Era Arrives in Glaucoma Medication, With Transformative Tech
Market Scope estimates pharmaceutical companies
will earn $1.9 billion from glaucoma medications
in the US in 2021, after discounts and rebates, and $4.8 billion worldwide.more >
-
2021-03-22
Steady Growth, New Technologies Will Drive Retinal Surgery Device Market to $1.36 Billion in 2026
The retinal surgical device market is expected
to total more than $1.14 billion in 2021,
with revenue rising to nearly $1.36 billion in 2026, according to a Market Scope report.more >
-
2021-01-29
COVID-19 and its impact on eye banking
The COVID-19 pandemic has affected
all areas of medicine, including eye banking.more >
-
2021-01-11
BLOG: The top ophthalmology research articles from 2020
Despite the COVID-19 pandemic, ophthalmology
research has continued at an exciting pace.more >
-
2020-12-18
Number of FDA new molecular entity approvals in 2020 similar to 2019
Despite the COVID19 pandemic, the FDA
approved 47 new molecular entities in 2020
including one for ophthalmology, compared with 48 in 2019, according to a speaker at the virtual Ophthalmology Innovation Summit Year in Review meeting.more >
-
2020-12-07
Cornea Products Market to Grow an Estimated 6.1 Percent Through 2025
Market Scope’s “2020 Cornea Products Market
Report” was published in Novembermore >
-
Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease
Following recent FDA approval of Biogen's
Alzheimer antibody drug ADUHELM (TM),
targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year.2021-06-16
-
Israel’s EyeYon Medical Receives CE Mark For Its Synthetic Implant
Israeli startup EyeYon Medical, announced
it has received a CE Mark for its minimally invasive
suture-free EndoArt implant after clinical trials demonstrated its safety and efficacy for treating chronic corneal edema.2021-06-08
-
NovaSight eyes FDA clearance with upcoming clinical trial
The company’s digital therapy CureSight presents
a new treatment method for amblyopia, also known
as lazy eye, that doesn’t require patching.2021-03-16
-
EyeYon Medical Raises $25 million in Series C to Transform Corneal Care
EyeYon Medical has developed the world's first synthetic
implant that enables doctors to treat chronic corneal edema
in a minimally invasive procedure without the use of human tissue or corneal donations.2021-03-15
